NDC 43742-2036 – Vir Combination

Influenza A Virus A/guangdong-maonan/swl1536/2019 Cnic-1909 (h1n1) Antigen (formaldehyde Inactivated) 12 [hp_X]/mL; Influenza A Virus A/hong Kong/2671/2019… · Liquid · Oral

Human Otc Drug

Product NDC43742-2036

Product details

Brand name
Vir Combination
Generic name
Influenzinum (2020-2021), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
Labeler
Deseret Biologicals, Inc.
Dosage form
Liquid
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
September 9, 2021
Marketing end
October 1, 2026
Pharmacologic class
Live Human Adenovirus Type 4 Vaccine; Live Human Adenovirus Type 7 Vaccine

Active ingredients

Uses, dosage, side effects and warnings for VIR Combination →

Package NDC codes (1)

Package NDCDescriptionSince
43742-2036-130 mL in 1 BOTTLE, DROPPER (43742-2036-1)Sep 9, 2021

Other VIR Combination products